Allspring Global Investments Holdings, LLC Dynavax Technologies Corp Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 13,432 shares of DVAX stock, worth $148,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,432

Previous 140,622 90.45%

Holding current value

$148,020

Previous $1.75 Million 91.4%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$10.73 - $12.58 $1.36 Million - $1.6 Million	-127,190 Reduced 90.45%	13,432 $150,000
Q1 2024 Apr 18, 2024	BUY	$11.7 - $14.98 $263,811 - $337,769	22,548 Added 19.1%	140,622 $1.75 Million
Q4 2023 Jan 25, 2024	BUY	$13.09 - $14.98 $1 Million - $1.15 Million	76,728 Added 185.58%	118,074 $1.65 Million
Q3 2023 Oct 27, 2023	BUY	$12.64 - $14.99 $522,613 - $619,776	41,346 New	41,346 $610,000
Q2 2023 Jul 18, 2023	BUY	$9.85 - $13.17 $162,623 - $217,436	16,510 Added 96.52%	33,615 $434,000
Q1 2023 Apr 13, 2023	SELL	$9.44 - $11.88 $736,282 - $926,592	-77,996 Reduced 82.01%	17,105 $167,000
Q4 2022 Jan 23, 2023	SELL	$10.27 - $13.29 $211,387 - $273,548	-20,583 Reduced 17.79%	95,101 $0
Q3 2022 Oct 26, 2022	SELL	$9.93 - $17.44 $2.19 Million - $3.84 Million	-220,467 Reduced 65.59%	115,684 $1.21 Million
Q2 2022 Jul 25, 2022	BUY	$7.45 - $12.83 $1.67 Million - $2.88 Million	224,261 Added 200.43%	336,151 $4.23 Million
Q1 2022 May 02, 2022	SELL	$9.75 - $14.44 $2.06 Million - $3.04 Million	-210,800 Reduced 65.33%	111,890 $1.21 Million
Q4 2021 Jan 28, 2022	BUY	$13.17 - $20.94 $4.25 Million - $6.76 Million	322,690 New	322,690 $4.54 Million

Others Institutions Holding DVAX

# of Institutions

259

Shares Held

132M

Call Options Held

371K

Put Options Held

99.2K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.39B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Dynavax Technologies Corp Transaction History